Physician

Kristi Jo Mcintyre, MD

According to 2025 Medicare claims, Kristi Mcintyre, MD (NPI: 1912949033) practices medical oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1003083445; TIN: 752131429) and primary practice location at 75231-7001. Mcintyre is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Mcintyre's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 616 traditional Medicare patients, billed 140,207 HCPCS/CPT codes, and received $1,927,831 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,451 prescription claims across 247 beneficiaries totaling $2,873,156 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 58 claims. Open Payments data shows 118 records totaling $228,995. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,282,975 to $1,927,831. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $767,185 to $2,873,156. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,353 to $901.